Principal Investigators: Dr Chris Pook, Liggins Institute, The University of Auckland
Industry partners: Riddet Institute, Human Nutrition Unit, Chia Sisters and AuOra of Wakatū Incorporation
High-Value Nutrition funding: $1,297,299
Tūhauora: a functional beverage containing kawakawa
AuOra and Chia Sisters have received funding from High-Value Nutrition Ko Ngā Kai Whai Painga for a three-part project. The focus is on kawakawa, a taonga species traditionally used as rongoā (traditional Māori medicine) for its analgesic, anti-inflammatory, and metabolic effects.
Part One: Led by the Riddet Institute, the manufacture of a dried kawakawa ingredient and functional food products will be explored.
Part Two: With research capabilities provided by the live-in Human Nutrition Unit, an intervention study will look at the effect of kawakawa on resting metabolic rate and utilisation of nutrients.
Part Three: The Liggins Institute will conduct a second human trial with kawakawa to quantify its effects on biomarkers of chronic inflammation, metabolic health and immune health.
AuOra is well regarded for its leadership role in pivoting New Zealand’s Primary Industries towards new high-value creation from bioactive ingredients and functional food for health solutions. Their work, in tandem with Chia Sisters, provides a fourfold opportunity to explore the bio-discovery value of kawakawa in ways that uphold tikanga, to extend and evolve the mātauranga continuum, to grow the Aotearoa New Zealand economy, and to contribute to the availability of dietary tools for the prevention of chronic disease.
Please refer to the Research Overview documents for more information about the High-Value Nutrition contestable funding scheme. High-Value Nutrition Ko Ngā Kai Whai Painga is one of the eleven National Science Challenges. The Challenge has a $45.6 million budgeted research investment over the next five years.
Dr Chris Pook
Chloe Van Dyke
Miriana is a lawyer, a director and a businesswoman who believes that Māori businesses can lead the way.
She believes that businesses entering into purposeful partnerships that share risk and rewards must deploy agile methodologies to update their products and services and with greater investment in innovation, science and technology.